Continuous technological advancements in autograft methods and emergence of tissue banks in developing countries are factors driving autograft market revenue growth
The global autograft market size is expected to reach USD 32.94 Billion in 2030 and register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of various chronic diseases which can lead to organ failure and growing need for autograft procedures across the globe are factors driving autograft market revenue growth to a significant extent.
Autograft is a process of removing an organ or tissue from the donor’s body and transplanting it into the recipient's body to replace a failed or damaged organ. Human organs such as kidney, lung, liver, pancreas, cornea, and skin can all be transplanted. Transplants aid in the restoration of a healthy body and help the patient live a healthy lifestyle. Technological advancements have helped in improving the success rate of transplants, and tissue transplants using advanced products are being performed at a significantly high rate. In addition, advanced software and systems make tissue and organ preservation more convenient.
The global market is expected to register robust revenue growth rate due to an increase in prevalence of various chronic diseases such as diabetes, cancer, heart disease, and renal disease, and an increase in incidence of burns and accidents, which can lead to organ failure. Organ transplants, tissue products, immunosuppressive drugs, and preservation solutions are in high demand. Market players are focusing on launching new products or developing new applications that combine patient’s existing organ and tissue procurement and preservation transplant services to meet autograft needs.
Key companies profiled in the report include
Veloxis Pharmaceuticals, Inc., Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc, Illumina, Inc., and QIAGEN.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/5099
The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Autograft market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.
Order this Report @ https://www.reportsanddata.com/report-pricing/5099
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.
The key geographical regions analyzed in the market report are:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Autograft Market Segmentation based on Types:
Product Outlook (Revenue, USD Billion; 2019–2030)
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solutions
Wound Type Outlook (Revenue, USD Billion; 2019–2030)
- Organ Transplant
- Tissue Transplant
End-use Outlook (Revenue, USD Billion; 2019–2030)
- Hospital
- Transplant Center
- Others
Some Key Highlights From the Report
- On February 2022, Hansa Biopharma AB, a Sweden-based company, announced that it has got authorization from French Haute Autorité de Santé (HAS) for Idefirix. The company will use Idefirix to desensitize highly sensitized patients undergoing kidney transplants.
- Tissue product segment accounted for largest revenue share in 2021 due to an increase in demand for tissue and organ autograft. Increasing prevalence of diseases including diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease has put a large population at risk of irreversible tissue damage, requiring a greater need for tissue autograft, which is expected to continue to drive revenue growth of the segment.
- Organ transplant segment accounted for largest revenue share in 2021. Organ autograft is the process of removing an organ from a donor and transplanting it into the patient's body to replace an organ. An increasing number of organ transplants are being performed around the world as a result of the high rate of organ failure caused by chronic diseases and an unhealthy lifestyle, which is driving revenue growth of the segment.
- Hospital segment accounted for largest revenue share in 2021 as a result of huge number of medical procedures and operations performed in hospitals. Most hospitals have accessibility to well-defined organ databases, which could be used to verify the supply of requested organs, allowing for quicker medical treatment.
- Market in North America accounted for largest revenue share in 2021. Development and innovation in autograft products and presence of vast biotechnology and medical product industries, as well as advanced healthcare facilities are factors driving revenue growth of autograft market in this region.
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/5099
Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Pediatric Hearing Aids Market @ https://www.biospace.com/article/pediatric-hearing-aids-market-size-2022-2028-growing-use-of-hearing-aids-owing-to-rising-prevalence-of-hearing-loss-among-children-and-increasing-awareness-among-parents-regarding-availability-of-advanced-hearing-aids-are-some-key-factors/
Digital Biology Market @ https://www.biospace.com/article/digital-biology-market-growth-global-survey-analysis-share-company-profiles-and-forecast-by-2027/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com